- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07931820
Translating Indoor Air Quality Data Into Action
Translating Indoor Air Quality Data Into Action: A Randomized Trial Of Tiered Information Strategies To Improve Household Air Quality
Poor indoor air quality affects the health of millions of Americans. People spend most of their time indoors, yet indoor air can be more polluted than outdoor air. Many everyday activities, such as cooking, using fireplaces, cleaning, and using air fresheners, affect indoor air quality, but most people don't know how their choices affect the air they breathe.
This study will test whether giving people information about their indoor air quality motivates them to make healthier choices. We will work with 120 households, providing them with air quality monitors and sending different types of information about their indoor air quality. Through randomized assignment, some will receive general tips, while others will get personalized messages based on their home's air quality patterns.
By understanding how to best help people create healthier indoor environments, respiratory health can e protected across diverse communities. This research could lead to practical, affordable ways for families to breathe cleaner air at home.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Kipruto Kirwa, PhD, MPH
- Numéro de téléphone: 617-358-1911
- E-mail: kirwa@bu.edu
Sauvegarde des contacts de l'étude
- Nom: Eliza Pentz, MS
- Numéro de téléphone: 617-358-3728
- E-mail: eppentz@bu.edu
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Is an active female participant in PRESTO (aged 21-45 years and trying to conceive at PRESTO enrollment, per PRESTO eligibility) who has completed the PRESTO baseline questionnaire and has not withdrawn from PRESTO.
- Lives in the United States and has a residence where a monitor can be safely placed for approximately four months after the baseline period.
- Has home Wi-Fi internet that the monitor can connect to.
- Has a smartphone or tablet that can run the monitor's companion app.
- Does not plan to move out of her current home within the next 6 months.
- Is willing to complete the study activities: monthly online questionnaires for 6 months, four 2-day activity logs, keeping the monitor plugged in at home for about 4 months, undergo random assignment, receiving study emails, text messages, and other communication, and returning the monitor at the end.
- Be able to provide informed consent in English.
Exclusion Criteria:
- Currently has an indoor air quality monitor in the home that displays levels of particles, VOCs, or CO2 (smoke alarms, carbon monoxide alarms, and radon detectors do not count). Rationale: households that already see IAQ data cannot provide a true "no-monitor" baseline period.
- Is an employee, student, or trainee of any member of the study team.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: LCM-O (monitor only)
Participants randomized to this arm will only receive a LCM-O monitor. |
Indoor air quality monitor with real-time display and companion app; standard setup and safety guide; routine study operational messages (e.g., questionnaire reminders), which contain no IAQ content. |
|
Comparateur actif: LCM-R (monitor + generic reminders)
Participants randomized to this arm will receive a LCM-O monitor and generic reminders. |
Everything in Arm 1, plus a brief generic IAQ tip and reminder to review the monitor every two weeks, drawn from a fixed library based on EPA guidance and the literature (8 messages over 4 months, starting 2 weeks after activation). |
|
Expérimental: LCM-I (monitor + personalized insights)
Participants randomized to this arm will receive a LCM-O monitor and personalized insights. |
Everything in Arm 1, plus a personalized message every two weeks that describes patterns in the household's own monitor data from the previous 14 days and suggests one or two specific actions, with links to further information (8 messages, starting 2 weeks after activation). |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Indoor Air Quality (IAQ) Behavior Score
Délai: Baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months
|
The IAQ Behavior Score measures how human actions, habits, or responses contribute to or mitigate indoor pollution. Data will be collected from a IAQ questionnaire. The score will range from 1-100 and higher scores are more favorable. |
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Kipruto Kirrwa, PhD, MPH, Boston University School of Public Health, Environmental Health
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- H-47323
- IAA-1579103 (Autre subvention/numéro de financement: American Lung Association)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .